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Objectives: Patients with tetralogy of Fallot and diminutive pulmonary arteries are
at risk for suprasystemic right ventricular pressure and right ventricular failure after
complete repair. We report the short-term outcome and medium-term follow-up
after using a fenestrated ventricular septal defect patch as a component of staged
repair in selected patients.
Methods: We reviewed 47 patients with tetralogy of Fallot and diminutive pulmo-
nary arteries whose ventricular septal defect patch was fenestrated, either electively
or as a rescue technique, at a single institution between 1984 and 2001.
Results: Early mortality was 10.6% and occurred only in patients who underwent
rescue fenestration. Review of medium-term follow-up (median, 39 months) re-
vealed 4 late deaths; an additional 4 patients experienced right ventricular failure
despite fenestration. Most (7/8) of these late events occurred in patients who
underwent planned fenestration. Excessive left-to-right shunt through the fenestra-
tion developed in only 2 patients.
Conclusions: Fenestrated patch closure of the ventricular septal defect in patients
with tetralogy of Fallot and diminutive pulmonary arteries resulted in 10.6% early
mortality. Used preemptively in selected patients, this technique is associated with
no surgical mortality and a low incidence of excessive left-to-right shunt (4%). Early
survivors remain at risk for late death and right ventricular failure despite fenestra-
tion.
Patients with tetralogy of Fallot (TOF) and pulmonary atresia who haveabsent or diminutive mediastinal pulmonary arteries (PAs) are at riskfor right ventricular (RV) hypertension and poor outcome after com-plete repair.1-3 In the mid-1980s we began to uniformly use a strategyof staged repair for these patients.4 In addition to decreasing overallmortality, we hoped to recruit pulmonary vasculature, reduce right-
to-left shunts, and preserve RV function. This staged approach prescribed early
establishment of RV to PA continuity, catheter-based intervention to increase
pulmonary conductance, and, ultimately, ventricular septal defect (VSD) closure.5,6
Inadequate relief of complex RV outflow obstruction before VSD closure risked
suprasystemic RV pressure, with resultant RV failure.
We performed our first VSD patch fenestration in 1984 and continued to use
fenestration as a rescue technique for patients with suprasystemic RV pressure
coming off cardiopulmonary bypass (CPB) until 1991. This early experience sug-
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gested the subsequent use of planned (elective) fenestration
in selected patients. We reasoned that a controlled residual
VSD, limiting RV pressure at the expense of systemic
desaturation, would reduce mortality in the postoperative
period. Furthermore, the availability of transcatheter de-
vices allowed for nonsurgical defect closure after further
interventions to improve pulmonary runoff.7 In this study
we describe early and late mortality associated with fenes-
trated patch VSD closure. We also report adverse outcomes
in an attempt to identify patients with morbidity as a result
of fenestration.
Methods
Patient Identification
We searched 4 databases to identify and obtain follow-up on
patients with TOF and a fenestrated VSD patch: the computerized
Cardiology Department database, the correspondence file from
cardiologists and surgeons, and the regulatory databases main-
tained for the Clamshell and CardioSEAL high-risk trials.
Anatomic and Clinical Data
We examined cineangiograms and hemodynamic data obtained at
catheterization for all patients. Pulmonary arterial size was deter-
mined according to the technique of Nakata and colleagues.2 If no
mediastinal PAs could be identified, then no value was assigned.
Ventricular pressures were drawn from the catheterization reports.
In cases of pulmonary flow arising exclusively through an aorto-
pulmonary shunt, PA oxygen saturations were measured directly
or assumed to be equal to aortic saturation. In cases of dual sources
of pulmonary flow, directly measured PA saturation values were
assumed to represent mixed samples. Echocardiography reports
were reviewed to determine RV pressure, functional status, and
patency of the fenestration. RV pressures were estimated on the
basis of Doppler velocity of the tricuspid regurgitant jet, and
systolic ventricular function was assessed qualitatively. Review of
operative reports yielded information on the size of the fenestra-
tion, the technique used to create it, and the conditions under
which it was placed (ie, planned or rescue).
Death, RV failure, and excessive left-to-right shunt comprised
the adverse outcomes of interest. Heart-lung transplantation has
not been used in the treatment of this disease at our center. Early
death was defined as death occurring before hospital discharge. RV
failure was defined as moderate-to-severe or severe RV dysfunc-
tion determined by means of echocardiography. We defined ex-
cessive left-to-right shunt as any shunt requiring intervention or a
pulmonary/systemic flow ratio (Qp/Qs) of greater than 2:1 at
catheterization. The fenestration was considered closed at the time
of the first echocardiographic or angiographic examination unable
to demonstrate transseptal flow.
Data are reported as a median with a range. After inspecting the
preliminary data, we chose to divide the patients into 2 groups for
the purposes of further analysis. Group 1 consisted of patients with
planned fenestration, and group 2 included those whose fenestra-
tion constituted a rescue procedure. Comparisons between groups
were performed by using the rank sum test and the Fisher exact
test. Preoperative and postoperative variables were compared by
using the signed-rank test for paired data. Freedom from death, RV
failure, and fenestration closure were analyzed by using the
Kaplan-Meier method. Permission for this retrospective chart re-
view was obtained from the Committee on Clinical Investigation.
Results
Between 1984 and 2001, 47 patients (27 female and 20 male
patients) with TOF and diminutive PAs underwent VSD
closure with a fenestrated patch at our institution. Follow-up
evaluations were performed at our institution in all but 2
patients, who had originally presented from outside the
United Stages (Figure 1).
Patient Characteristics
The majority of patients (44/47 [94%]) had TOF with pul-
monary atresia, and 3 patients had TOF with severe pulmo-
nary stenosis. Median age at surgical intervention was 4
years (1 month to 30 years); 34 patients had previously
undergone palliative surgery, and 21 of these procedures
included an aortopulmonary shunt. We pursued preopera-
tive catheterization to evaluate and augment the pulmonary
vascular bed in all patients. Catheter interventions included
balloon dilation and stenting of the branch PAs (n  31).
Coil occlusion of aortopulmonary collaterals was performed
in patients (n  25) who met previously described criteria
on the basis of the premise that these vessels represent
unreliable sources of pulmonary blood flow.4,8 The median
systemic arterial oxygen saturation at the preoperative cath-
eterization was 83% (71%-100%), with a corresponding
hemoglobin concentration of 15.3 g/dL (11.7-19.1 g/dL)
and a Qp/Qs of 1.1 (0.4-2.5). Pulmonary angiography al-
lowed for assignment of a Nakata index in 41 of 47 patients.
This value ranged from 27 to 193 mm2/m2, with a median
value of 99 mm2/m2.
Figure 1. Flow diagram depicting dispositions of all 47 retrospec-
tively identified patients with TOF who had fenestrated patch
closure of VSD.
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Operation
At the time of operation, 41 patients underwent right ven-
tricular outflow tract (RVOT) reconstruction before place-
ment of the fenestrated VSD patch. This reconstruction
consisted of establishment of right ventricle to PA continu-
ity in 25 patients and revision of an existing outflow tract in
an additional 16 patients. A pulmonary valve was incorpo-
rated in 36 of the RVOTs, which were predominantly ho-
mografts. A quarter of the patients (n  12) had surgical
enlargement of branch PAs before VSD closure. In 18
patients, some of whom had undergone previous unifocal-
ization, pulmonary vessels were unifocalized at the time of
repair. In total, 20 patients had unifocalization before or at
the time of repair.
Fenestrations were created either by excising a central
portion of the patch or by using a punch device (most
commonly 4 mm). The defects were roughly circular, at
least 2 mm in diameter, and centrally located in the patch to
facilitate future transcatheter closure. In 27 patients (57%;
group 1, planned) Dacron patches were electively fenes-
trated at the time of VSD closure. In the other 20 patients
(43%; group 2, rescue), fenestrations were placed in the
VSD patch after an initial weaning from CPB resulted in
suprasystemic RV pressure or evidence of acute RV failure.
In 4 of these cases the patients were initially taken to the
intensive care unit postoperatively with an intact patch and
later returned to the operating room for fenestration. The
remaining 16 patients who underwent rescue fenestration
did so immediately, although 2 required later fenestration
enlargement.
Analysis by Group
The 2 groups were similar with regard to a number of
preoperative and operative variables (Table 1). Because of
our increasing use of the planned patch fenestration, patients
in group 2 were more likely to have been operated on before
1995 (16/20 [80%] vs 7/27 [26%], P  .001). Group 1
patients were somewhat more likely to have a preexisting
RVOT and were more likely to have had catheter interven-
tion to improve the pulmonary vascular bed before repair (P
 .01).
There were 5 early deaths, occurring within 6 days of the
operation. Early deaths occurred only in group 2, the rescue
group. These deaths were attributable to suprasystemic RV
pressure, acute RV failure, and low cardiac output (Table 2).
Both patients who required fenestration enlargement died.
Patients who died were younger than survivors (0.9 vs 5.0
years, P  .04), with a nonsignificant tendency toward a
lower Nakata index than survivors (median  67 vs 100
mm2/m2, P  .18).
Two patients were supported postoperatively with extra-
corporeal membrane oxygenation (ECMO). One of these
was among the early deaths. The second patient was sup-
ported for 48 hours, was successfully decannulated, and
survived to hospital discharge 14 days later. Two patients
received inhaled nitric oxide in an attempt to attenuate
postoperative pulmonary hypertension. None of the patients
required VSD closure before hospital discharge.
Follow-up
Median duration of follow-up was 39 months (range, 1-146
months). Postdischarge evaluations, available for 40 of 42
early survivors, included echocardiography and catheteriza-
tion. In 29 patients with adequate echocardiographic studies
to estimate RV pressure, the ratio of RV to systemic arterial
pressure was 0.72 (0.35-1.07). At postoperative catheteriza-
tion, directly measured RV pressures were 89% (60%-
110%) of systemic pressure in 39 patients. Patients with RV
pressures at or above systemic levels had further catheter
interventions to improve pulmonary runoff. Late fenestra-
tion enlargement or recreation of the fenestration was not
Figure 2. Actuarial survival after fenestrated patch closure of
VSD in 47 patients with TOF and diminutive PAs. Dotted lines
represent 95% confidence limits.
TABLE 1. Group characteristics
Group 1 (planned)
(n  27)
Group 2 (rescue)
(n  20) P value
Age (y) 5.3 3.5 .56
Prior shunt 13 (48%) 8 (40%) .77
Prior outflow tract 15 (55%) 6 (30%) .14
Nakata index (mm2/m2) 99 96 .59
Prior catheter
intervention
22 (81%) 9 (45%) .01
Unifocalized 14 (52%) 6 (30%) .15
Circulatory arrest 4 (15%) 4 (25%) .47
Fenestration size (mm) 4 5 .10
Early death 0 5 (25%) .01
Late death 3 (12%) 1 (5%) .62
RV failure 4 (16%) 0 (0%) .12
Excessive shunt 2 (8%) 1 (5%) 1.00
Values are presented as a median or as the number of patients within the
group, with the percentage of patients in the group in parentheses.
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attempted in any of the patients. Arterial oxygen saturations
were significantly higher than preoperative values (92% vs
83%, P .001), and hemoglobin levels were lower (13.5 vs
15.3 g/dL, P  .009). The Qp/Qs ratio remained unchanged
for the group as a whole (1.1 preoperatively vs 1.0 postop-
eratively).
Four patients died between 8 months and 4 years post-
operatively, resulting in 76% actuarial survival at 5 years
(confidence interval [CI]  57%-87%, Figure 2). Three of
the 4 late deaths occurred in patients in the planned fenes-
tration group. Patients with late mortality were not younger
than the remainder of the follow-up group (P .50) and did
not have significantly different Nakata indexes (P  .80).
The causes of death varied. The first patient died in the
hospital 8 months postoperatively, when he presented with
an acute, infectious pulmonary process. The second patient
died in the hospital of severe, idiopathic left ventricular
(LV) dysfunction, presenting 3 years after the operation.
The third patient died at catheterization 4 years postopera-
tively as a result of uncontrolled hemorrhage after a com-
plicated PA dilation. This patient and his complication have
been reported previously.9 The final patient who experi-
enced late death underwent a rescue fenestration and died
suddenly at home 1 year after the operation. After his repair,
he had undergone successful surgical intervention for clo-
sure of an LV to right atrial shunt. He also had a history of
atrial and ventricular arrhythmias for which he was being
medically treated.
Four patients had RV failure evidenced by qualitatively
severely decreased RV function and associated tricuspid
regurgitation. All had strikingly poor pulmonary vascula-
ture. Two patients did not have measurable Nakata indexes,
and the other 2 patients had indexes of 36 and 65 mm2/m2.
All went to the operating room anticipating marginal hemo-
dynamics and fenestration of the VSD patch, and one of the
4 required ECMO support for 48 hours. RV failure, diag-
nosed between 6 and 24 months postoperatively, developed
despite a patent fenestration in all 4 patients.
Both death and RV failure occurred years after fenes-
trated VSD closure but were rare among early survivors of
rescue fenestration. Only one of 15 early survivors in group
2 died during follow-up, and none had late RV failure. In
contrast, 7 of 27 early survivors in group 1 went on to
experience death or RV failure in the follow-up period. As
a whole, 66% of patients remained free from death or RV
failure at 5 years after the operation (CI  48%-79%).
Excessive left-to-right shunt developed in 3 patients; all
other survivors had a Qp/Qs of less than 1.5:1. In one
patient persistence of a large shunt after transcatheter clo-
sure of a residual VSD led to the diagnosis of an unrecog-
nized LV to right atrial defect. This lesion was closed
operatively, but the patient died suddenly months later, as
was discussed earlier. Two additional patients required
VSD closure. The first of these patients had required rescue
fenestration, despite a Nakata index of 167 mm2/m2. She
had a Qp/Qs of 1.7:1 at postoperative catheterization and
had her VSD closed surgically. The second patient, with a
Nakata index of 115 mm2/m2, underwent planned fenestra-
tion and proceeded to have PA dilations at 3 catheterizations
over the next 5 years. At the conclusion of the third proce-
dure, his Qp/Qs was 3:1, and a device was placed in his
residual VSD. Thus only one patient who was electively
fenestrated (1/27 [4%]) eventually required closure of the
defect because of excessive left-to-right shunting.
By 1 year after the operation, 39% (CI  24%-57%) of
the fenestrations were closed (Figure 3). Among patients
returning for follow-up, 24 (24/40 [60%]) were known to
have a closed fenestration at their most recent examination.
Nearly half of these fenestrations closed spontaneously
(11/24 [46%]). Other mechanisms of closure included trans-
catheter device placement (7/24 [29%]) and surgical patch-
ing (6/24 [25%]). The intended benefits of interventional
closure included reduction of LV volume load and elimina-
tion of the potential for cyanosis or paradoxical emboli. In
5 of 6 patients undergoing surgical defect closure, this was
accomplished at the same operation as additional RVOT
TABLE 2. Early deaths
Age Nakata index Year Description
3 y 67 mm2/m2 1984 Suprasystemic in ICU. Returned to OR next day to create fenestration.
Died in OR.
10 mo 53 mm2/m2 1985 Suprasystemic in ICU. Returned to OR on POD 3 to enlarge
fenestration. Died on arrival to ICU.
5 d 108 mm2/m2 1986 ECMO for low cardiac output from OR until reoperation on POD 6.
Died in OR.
3 mo 99 mm2/m2 1990 Suprasystemic in ICU. Returned to OR same day to create
fenestration. Died on POD 1.
4 y 54 mm2/m2 1991 Suprasystemic in OR. Fenestration enlarged. Persistent low output
and cardiac arrest. Died on POD 1.
Early death was defined as death occurring before hospital discharge. ICU, Intensive care unit; OR, operating room; POD, postoperative day.
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augmentation. Overall, 26% (11/42) of the early survivors
required a subsequent operation for purposes of RVOT
augmentation. Patients who did not require reoperation
were considered for catheter closure of the fenestration at
the time of additional PA interventions (Figure 4).
Discussion
Despite a number of proposed methods to predict which
patients with TOF and diminutive PAs will tolerate com-
plete repair, none has proved to be ideal.1,2,10,11 Early
1-stage unifocalization, when performed in conjunction
with an intraoperative pulmonary flow study, has allowed
complete repair in 66% of patients, with a 10.6% perioper-
ative mortality.12 Staged repair, although requiring multiple
operations and deferring relief of right-to-left shunt, allows
for VSD closure to be considered over time in the context of
ongoing RVOT and PA optimization. A recent report dem-
onstrated the benefits of staged repair in a large series of
patients with TOF and pulmonary atresia.13 The authors
found that the need to reopen a VSD in the operating room
was predictive of both early and late mortality in patients
undergoing complete repair.
In 1988, Kirklin and colleagues3 reported risk factors for
death after complete repair of TOF/PA, encompassing an
experience of nearly 20 years. During this time period, the
authors found 17 patients in whom complete repair failed,
with an RV/LV pressure ratio of greater than 1:1. In these
patients the VSD patch was perforated or removed. Out-
comes after partial or complete takedown of the VSD patch
were not discussed in the body of the article, but the authors
noted that 8 (47%) of these 17 patients died in the hospital,
and 2 patients died later. In a series of 34 patients with
pulmonary atresia, VSD, and multiple aortopulmonary col-
laterals reported by Sawatari and associates,14 4 had supra-
systemic RV pressure after VSD closure. The authors de-
scribed perforation of the VSD patch in these 4 patients,
with one late death. Iyer and Mee15 reported a series of 58
patients, in which 2 of 3 late deaths occurred in patients who
had suprasystemic RV pressures and returned to the oper-
ating room for patch perforation.
We reviewed our own experience with fenestrated patch
VSD closure in a selected group of patients with TOF and
diminutive PAs. Within this retrospectively identified group
of patients with a median Nakata index of 99 mm2/m2, PA
anatomy and prior surgical interventions were highly var-
ied. These patients had catheterization and operations per-
formed at our center over a 17-year time period, during
which we attempted to standardize our approach to this
heterogeneous population. Initially, we used patch fenestra-
tion as a rescue procedure for those patients who failed to be
separated from CPB after complete repair. We ultimately
used the fenestrated VSD patch in an elective, anticipatory
manner.
In our series of 47 selected patients, early mortality was
10.6%. Early death occurred only in patients who had
fenestrations placed as a rescue maneuver after initially
failing to be separated from CPB. There were no early
deaths among the 27 patients who received elective patch
fenestration.
Given that most of the electively fenestrated patients
were operated on in the latter half of the described experi-
ence, a number of improvements in the overall care of these
patients are likely to have contributed to this clear differ-
ence in postrepair mortality. Patients in group 1 were some-
what more likely to have established right ventricle to PA
continuity before repair and were more likely to have un-
dergone interventional catheterization for pulmonary arte-
rial rehabilitation. Improvements in surgical RVOT recon-
struction or PA plasty might also have contributed to lower
early mortality, and subtle changes in surgical technique
were not investigated in this study. Need for circulatory
arrest did not differ between the 2 groups. Despite the
increasing availability of inhaled nitric oxide and ECMO
during the study period, these modalities were used infre-
quently in this population of patients.
We propose that the incidence of early death in this
group of patients was minimized by placing a fenestration at
the time of VSD closure and protecting the postoperative
right ventricle from suprasystemic pressure. Furthermore,
placing the fenestration in an anticipatory way appears to
have been more protective than placing it as a rescue ma-
neuver. Patients in group 2 might have been more vulner-
able because of the brief exposure to suprasystemic RV
pressure before fenestration, as well as the need for reinsti-
tution of CPB after the determination of RV failure.
In follow-up none of the survivors in group 2 had late RV
failure, and the group experienced only one late death. This
might be due to selection imposed during the immediate
postoperative period. The patients in group 2 with the poor-
est pulmonary runoff and the highest risk of acute RV
Figure 3. Freedom from fenestration closure. Dotted lines repre-
sent 95% confidence limits.
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failure might have succumbed postoperatively, whereas pa-
tients in group 1 did not die early but manifested their
persistent pulmonary vascular inadequacy by having RV
failure in follow-up.
Among the 27 early survivors in group 1, there were 3
late deaths. In addition, 4 patients had RV failure. The risk
of RV failure presumably persisted on the basis of a se-
verely impaired pulmonary vascular bed with distal abnor-
malities and microvascular changes.16 Fenestration might
have permitted survival through the postoperative period,
but underlying pulmonary anatomy continued to impose a
chronic stress on the right ventricle. Although potentially
beneficial, fenestration enlargement has not been pursued in
these patients in favor of additional interventions to mini-
mize RVOT obstruction and to maximize pulmonary runoff.
Of 3 patients who required intervention for excessive
left-to-right shunt, 2 were in the rescue group and had
already demonstrated their inability to support a postoper-
ative circulation in the absence of a fenestration. The mech-
anism of residual shunt in one of these patients was left
ventricle to right atrium, and despite surgical correction, this
patient died in follow-up. Puga and colleagues17 have pre-
viously reported severe RV failure as the result of an LV to
right atrial shunt after repair. The single patient in our series
who had an elective fenestration and subsequently required
VSD closure did so only after multiple PA dilations led to
excessive pulmonary flow.
Follow-up has shown that many of these fenestrations
with a median size of 4 mm will close spontaneously. In the
event of persistence of the fenestration, the size and location
of the residual defect make it amenable to either surgical or
transcatheter closure. Reoperation is often necessary for
revision of the RVOT in these patients, at which time the
fenestration can be closed.18 Similarly, these patients un-
dergo additional catheterizations for ongoing management
of PA stenoses and hypoplasia.12,19,20 At these procedures,
fenestrations can be closed by using a catheter-based de-
vice.7,21
Our adoption of an institutional approach to management
of this disease limits our ability to generalize our findings,
and the small number of patients involved precludes any
detailed analysis of predictors. However, our results after
planned fenestration are in distinct contrast to the figures
presented by Kirklin and colleagues3 and Cho and cowork-
ers,13 which depict a high mortality associated with a need
for reopening the VSD, even partially. More recent tech-
niques, such as early 1-stage unifocalization and repair,
have also yielded improved outcomes over past experience.
At this time, all of these approaches remain vulnerable to
inappropriate decisions regarding VSD closure. Regardless
of the primary management strategy, elective patch fenes-
tration could minimize adverse outcomes after repair in the
setting of an inadequate pulmonary vascular bed. We cur-
rently place an elective fenestration in the VSD patch in the
absence of a net left-to-right shunt preoperatively, with
limited opportunity to improve PA runoff at the time of the
operation. Through additional clinical experience, we plan
to improve patient selection and fenestration techniques.
In the absence of methods to reliably predict readiness
for complete repair, routine application of a modified,
Figure 4. Angiograms taken during device closure of a patch fenestration. Left, An angiographic catheter passes
from the right ventricle to the left ventricle through the fenestration in the ventricular septal patch. The large black
arrow identifies the catheter in the right ventricle. Small black arrows demonstrate curvature of the VSD patch.
The large white arrow points out the underside of the aortic cusp. Right, After placement of a double-umbrella
device, angiography at the level of the aortic valve outlines the LV surface of the septum. The central body of the
device sits in the fenestration, with 4 arms on either side of the septum.
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staged, surgical approach has allowed us to improve the
survival of patients with TOF and diminutive PAs. This
modified approach uses a fenestration in the ventricular
septal patch. The fenestration can be placed after VSD
closure to rescue patients who are unable to be separated
from CPB. However, early survival is greatest when the
fenestration is placed in an elective manner. Late mortality
and RV failure occur in a small percentage of patients
despite use of this technique and might be attributable to
inadequate preparation of the pulmonary vascular bed. Risk
of excessive left-to-right shunt postoperatively is low when
the fenestration is limited to approximately 4 mm, and many
of the fenestrations will close spontaneously or can be
closed at subsequent surgical or catheterization procedures.
We thank Kimberlee Gauvreau for her invaluable assistance
with the statistical analysis, and Emily and Bill McIntosh for their
assistance with the preparation of the figures.
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